59
Participants
Start Date
May 18, 2023
Primary Completion Date
April 4, 2025
Study Completion Date
April 4, 2025
BP
Blood pressure measurements and HbA1c tests will be conducted to identify participants with or at risk for high blood pressure and/or Type 2 Diabetes. Those identified will be referred to PCP for follow up/treatment.
HbA1c
HbA1c will screen to identify patients with Type 2 diabetes
PCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKD
Guidelines will be developed and provided to PCPs to use with their Hispanic/Latinx patients with or at risk for CKD.
Duke University Medical Center, Durham
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
Duke University
OTHER